These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 17117015

  • 1. Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes.
    Xu J, Ren L, Huang X, Qiu C, Liu Y, Liu Y, Shao Y.
    AIDS; 2006 Nov 28; 20(18):2293-303. PubMed ID: 17117015
    [Abstract] [Full Text] [Related]

  • 2. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
    Huang XG, Xu JQ, Ren L, Qiu C, Zhang N, Liu LX, Wan YM, Peng H, Shao YM.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 28; 86(44):3109-13. PubMed ID: 17313761
    [Abstract] [Full Text] [Related]

  • 3. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR, Bhonge LS, Lakhashe SK, Shankarkumar U, Sane SS, Kulkarni SS, Mahajan BA, Paranjape RS.
    J Infect Dis; 2005 Sep 01; 192(5):749-59. PubMed ID: 16088824
    [Abstract] [Full Text] [Related]

  • 4. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K, Xin KQ, Jounai N, Kojima Y, Tamura Y, Okada E, Kawamoto S, Okuda K, Klinman D, Okuda K.
    Vaccine; 2004 Sep 09; 22(27-28):3676-90. PubMed ID: 15315847
    [Abstract] [Full Text] [Related]

  • 5. Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.
    Wild J, Bojak A, Deml L, Wagner R.
    Vaccine; 2004 Apr 16; 22(13-14):1732-43. PubMed ID: 15068857
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
    Megede JZ, Otten GR, Doe B, Liu H, Srivastava R, Greer C, Legg H, Tang T, Polo JM, Donnelly JJ, Ulmer JB, Barnett SW.
    Vaccine; 2006 Apr 05; 24(15):2755-63. PubMed ID: 16460840
    [Abstract] [Full Text] [Related]

  • 7. Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.
    Huang X, Liu L, Ren L, Qiu C, Wan Y, Xu J.
    Vaccine; 2007 Dec 17; 25(52):8874-84. PubMed ID: 18061316
    [Abstract] [Full Text] [Related]

  • 8. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
    Shinoda K, Xin KQ, Kojima Y, Saha S, Okuda K, Okuda K.
    Clin Immunol; 2006 Apr 17; 119(1):32-7. PubMed ID: 16458074
    [Abstract] [Full Text] [Related]

  • 9. Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques.
    Amara RR, Sharma S, Patel M, Smith JM, Chennareddi L, Herndon JG, Robinson HL.
    Virology; 2005 Mar 30; 334(1):124-33. PubMed ID: 15749128
    [Abstract] [Full Text] [Related]

  • 10. A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes.
    Lorin C, Delebecque F, Labrousse V, Da Silva L, Lemonnier F, Brahic M, Tangy F.
    Vaccine; 2005 Aug 22; 23(36):4463-72. PubMed ID: 15993518
    [Abstract] [Full Text] [Related]

  • 11. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D, Matsuo K, Pinyosukhee N, Thongdeejaroen W, Leang-Aramgul P, Sawanpanyalert P, Warachit P.
    Southeast Asian J Trop Med Public Health; 2009 Mar 22; 40(2):273-81. PubMed ID: 19323012
    [Abstract] [Full Text] [Related]

  • 12. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
    Akahata W, Yang ZY, Nabel GJ.
    J Virol; 2005 Jan 22; 79(1):626-31. PubMed ID: 15596858
    [Abstract] [Full Text] [Related]

  • 13. Chimeric adenovirus 5/35 vector containing the clade C HIV gag gene induces a cross-reactive immune response against HIV.
    Xin KQ, Sekimoto Y, Takahashi T, Mizuguchi H, Ichino M, Yoshida A, Okuda K.
    Vaccine; 2007 May 10; 25(19):3809-15. PubMed ID: 17386962
    [Abstract] [Full Text] [Related]

  • 14. Prime-boost immunization with DNA, recombinant fowlpox virus and VLP(SHIV) elicit both neutralizing antibodies and IFNgamma-producing T cells against the HIV-envelope protein in mice that control env-bearing tumour cells.
    Radaelli A, Bonduelle O, Beggio P, Mahe B, Pozzi E, Elli V, Paganini M, Zanotto C, De Giuli Morghen C, Combadière B.
    Vaccine; 2007 Mar 01; 25(11):2128-38. PubMed ID: 17241705
    [Abstract] [Full Text] [Related]

  • 15. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S, Marini E, Bozzo L, Trainini L, Saadoune L, Avolio M, Pontillo A, Bonfanti C, Sarmientos P, Caruso A.
    Biopolymers; 2004 Mar 01; 76(4):334-43. PubMed ID: 15386266
    [Abstract] [Full Text] [Related]

  • 16. Design of immunogens as components of a new generation of molecular vaccines.
    Loktev VB, Ilyichev AA, Eroshkin AM, Karpenko LI, Pokrovsky AG, Pereboev AV, Svyatchenko VA, Ignat'ev GM, Smolina MI, Melamed NV, Lebedeva CD, Sandakhchiev LS.
    J Biotechnol; 1996 Jan 26; 44(1-3):129-37. PubMed ID: 8717396
    [Abstract] [Full Text] [Related]

  • 17. The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.
    Gavioli R, Cellini S, Castaldello A, Voltan R, Gallerani E, Gagliardoni F, Fortini C, Cofano EB, Triulzi C, Cafaro A, Srivastava I, Barnett S, Caputo A, Ensoli B.
    Vaccine; 2008 Jan 30; 26(5):727-37. PubMed ID: 18096278
    [Abstract] [Full Text] [Related]

  • 18. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S, Feng X, Shu T, Matano T, Hasegawa M, Wang X, Ma H, Li H, Li Z, Zeng Y.
    Vaccine; 2008 Nov 11; 26(48):6124-31. PubMed ID: 18812199
    [Abstract] [Full Text] [Related]

  • 19. Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.
    Hovav AH, Cayabyab MJ, Panas MW, Santra S, Greenland J, Geiben R, Haynes BF, Jacobs WR, Letvin NL.
    J Virol; 2007 Jan 11; 81(1):74-83. PubMed ID: 17050608
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1.
    Ranasinghe C, Medveczky JC, Woltring D, Gao K, Thomson S, Coupar BE, Boyle DB, Ramsay AJ, Ramshaw IA.
    Vaccine; 2006 Jul 26; 24(31-32):5881-95. PubMed ID: 16759767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.